These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. Kelly PA; Mann DE; Damle RS; Reiter MJ J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs. Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001 [TBL] [Abstract][Full Text] [Related]
6. Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy. Porterfield JG; Porterfield LM; Smith BA; Bray L Am J Cardiol; 1993 Aug; 72(3):301-4. PubMed ID: 8342508 [TBL] [Abstract][Full Text] [Related]
8. The current status of the implantable cardioverter defibrillator. Gillis AM Annu Rev Med; 1996; 47():85-93. PubMed ID: 8712805 [TBL] [Abstract][Full Text] [Related]
9. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group. Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117 [TBL] [Abstract][Full Text] [Related]
10. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. Hurwitz JL; Hook BG; Flores BT; Marchlinski FE J Am Coll Cardiol; 1993 Mar; 21(4):895-900. PubMed ID: 8450157 [TBL] [Abstract][Full Text] [Related]
11. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators. Porterfield JG; Porterfield LM; Smith BA; Bray L; Voshage L; Martinez A Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):170-3. PubMed ID: 7681566 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group. J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508 [TBL] [Abstract][Full Text] [Related]
14. The pacer-cardioverter-defibrillator: function and clinical experience. Friedman PA; Stanton MS J Cardiovasc Electrophysiol; 1995 Jan; 6(1):48-68. PubMed ID: 7743010 [TBL] [Abstract][Full Text] [Related]
15. Implantation and follow-up of a third-generation cardioverter defibrillator: comparison of epicardial and nonthoracotomy defibrillation lead system. Trappe HJ; Fieguth HG; Pfitzner P; Heintze J; Wenzlaff P; Kielblock B; Lichtlen PR J Interv Cardiol; 1995 Jun; 8(3):219-28. PubMed ID: 10155232 [TBL] [Abstract][Full Text] [Related]
16. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations. Natale A; Sra J; Axtell K; Akhtar M; Newby K; Kent V; Geiger MJ; Brandon MJ; Kearney MM; Pacifico A Circulation; 1996 Jan; 93(1):91-8. PubMed ID: 8616948 [TBL] [Abstract][Full Text] [Related]
17. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation]. Siebels J; Schneider MA; Kuck KH Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group. Neuzner J Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230 [TBL] [Abstract][Full Text] [Related]
19. Limitations of tachycardia confirmation and rate classification algorithms in a third-generation implantable cardioverter defibrillator. Stambler BS; Wood MA; Ellenbogen KA Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 1):1618-28. PubMed ID: 8946459 [TBL] [Abstract][Full Text] [Related]